Women: Here’s the most important article you should read, if you are considering Flibanserin (Addyi) for low sex drive.
Want to know what I think the most appalling fact is? It’s that testing for this drug used 23 men and 2 (two! 2!) women. What the heck? Why did they use men at all? This is simply unbelievable.
Flibanserin, the drug for hypoactive sexual desire disorder in women (a condition that many argue doesn’t exist as for many women sexual desire is responsive, not spontaneous) has been approved by the FDA and will be sold under the brand name Addyi.
I’m underwhelmed and concerned about flibanserin for a variety of reasons, but I want to focus on one very specific and important point about the drug that appears in the REMS (Risk Evaluation and Mitigation Strategy) required by the FDA. For those of you who may not know REMS is required by the FDA for certain drugs that have a greater risk of serious complications. Some drugs require an 8 hour training course, but with Addyi all a doctor has to do is read 12 Power Point slides, answer a couple of questions, and submit a form – truly as Sprout says “3 Easy Steps.” Because yes, you…
View original post 356 more words